Approximately 80% of all patients with NMOSD test positive for anti-AQP4 antibodies. During the phase 3 trial, MRI imaging was conducted on the spinal cord, optic nerve, and brain/brain stem to ...
Some results have been hidden because they may be inaccessible to you